Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.


Paul G. Allen Frontiers Group [to 24 Apr 2021]
[Website not responding at inquiry]


BARDA – U.S. Department of HHS [to 24 Apr 2021]
No new digest content identified.


BMGF – Gates Foundation [to 24 Apr 2021]
Press Releases and Statements
No new digest content identified.


Bill & Melinda Gates Medical Research Institute [to 24 Apr 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.


CARB-X [to 24 Apr 2021]
04.20.2021  |
CARB-X is funding Baebies Inc. to develop a rapid diagnostic for neonatal sepsis
CARB-X is awarding Baebies Inc., based in Durham, North Carolina, USA, up to $3.9 million to develop a rapid easy-to-use diagnostic for neonatal sepsis, a severe condition related to bacterial infections which, according to studies, kills an estimated 1.4 million young children world-wide each year.

04.19.2021  |
CARB-X is funding Phico Therapeutics to develop an engineered bacteriophage drug to treat ventilator-associated pneumonia caused by drug-resistant Pseudomonas aeruginosa
CARB-X is funding Phico Therapeutics, in Cambridge, UK, to develop a new intravenous engineered bacteriophage drug to treat ventilator-associated pneumonia caused by Pseudomonas aeruginosa, a serious problem in hospitals, intensive-care units and health-care settings.


Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 24 Apr 2021]
:: Past weekly editions of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Webinar Recording – Posting of Informed Consent Content on Clinical Trials Registries Center for Informed Consent Integrity Webinar Series – 21 April 2021


CEPI – Coalition for Epidemic Preparedness Innovations [to 24 Apr 2021]
Latest News
No new digest content identified.


DARPA – Defense Advanced Research Projects Agency [to 24 Apr 2021
DARPA Selects Teams to Defend Against Chemical, Biological Threats from Inside and Out
Chemical and biological (CB) threats have become increasingly ubiquitous and diverse, presenting significant risks to warfighters in theater and stability operators during pandemic outbreaks. State-of-the-art personal protective equipment (PPE) can be bulky, heavy, and cumbersome, often severely limiting user mobility and performance. The Personalized Protective Biosystem (PPB) program aims to develop technology that reduces the need for burdensome protective equipment while increasing individual protection against CB threats.


Duke Global Health Innovation Center [to 24 Apr 2021]
Last dated update: FRIDAY, April 2, 2021


EDCTP [to 24 Apr 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
24 April 2021
EDCTP-funded trial of R21/Matrix-M malaria vaccine shows efficacy of 77%
Positive results from an EDCTP-funded clinical trial in Burkina Faso, published as a preprint with The Lancet, demonstrate that the malaria vaccine candidate R21/Matrix-M is safe, immunogenic and has an efficacy of 77%, exceeding the WHO goal of 75% efficacy for malaria vaccines.
[University of Oxford news item: Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal]


Emory Vaccine Center [to 24 Apr 2021]
Vaccine Center News
No new digest content identified.


European Vaccine Initiative [to 24 Apr 2021]
Latest News
World Malaria Day 2021: Reaching the zero malaria target by 2030


FDA [to 24 Apr 2021]
Press Announcements /Selected Details
April 23, 2021 – FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
[See COVID U.S. above for detail]

April 23, 2021 – Coronavirus (COVID-19) Update: April 23, 2021

April 21, 2021 – FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
…As part of our regulatory processes for reviewing all manufacturing facilities, the FDA recently completed an inspection of Emergent BioSolutions, a proposed manufacturing facility for the Johnson & Johnson COVID-19 Vaccine. As Johnson & Johnson announced last month, the FDA has not authorized this facility to manufacture or distribute any of Johnson & Johnson’s COVID-19 Vaccine or components and, to date, no COVID-19 vaccine manufactured at this plant has been distributed for use in the U.S.
The FDA’s inspections are thorough, and these assessments review the quality of manufacturing procedures, including records, staff training, facility operations, drug production and testing and the systems in place to ensure product quality. During an inspection of Emergent BioSolutions that ended Tuesday, the FDA cited a number of observations concerning whether the facility’s processes met our requirements and standards. These observations are outlined in our inspection closeout report, also known as a “FDA Form 483.”…

April 20, 2021 – Coronavirus (COVID-19) Update: April 20, 2021


Fondation Merieux [to 24 Apr 2021]
News, Events
No new digest content identified.


Gavi [to 24 Apr 2021]
News Releases
23 April 2021
France makes important vaccine dose donation to COVAX
[See COVAX above for detail]


GHIT Fund [to 24 Apr 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.


Global Fund [to 24 Apr 2021]
News & Stories
Global Fund Applauds Netherlands’ Contribution to ACT-Accelerator
20 April 2021
The Global Fund warmly welcomed the announcement by the Netherlands of a contribution of €52 million to the Access to COVID-19 Tools (ACT) Accelerator – a groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Of the new funds, €12 million will be channeled through the Global Fund to strengthen its response to the COVID-19 pandemic while protecting gains made against HIV, tuberculosis, and malaria over the last two decades. The rest, €40 million, will be invested in the purchase of vaccines through COVAX – the vaccines pillar of the ACT-Accelerator. This latest commitment follows €85 million the Netherlands has contributed to the global response to COVID-19 since the pandemic began, bringing its total investment to date to €137 million…


Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 24 Apr 2021]
No new digest content identified.


Hilleman Laboratories [to 24 Apr 2021]
No new digest content identified.


Human Vaccines Project [to 24 Apr 2021]
No new digest content identified.
[Website not fully loading at inquiry]


IAVI [to 24 Apr 2021]
No new digest content identified.



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.


ICRC [to 24 Apr 2021]
Selected News Releases, Statements, Reports
No new digest content identified.



International Generic and Biosimilar Medicines Association [IGBA]
No new digest content identified.



Press Releases/Announcements
No new digest content identified.


IFRC [to 24 Apr 2021]
Selected Press Releases, Announcements
Europe, Greece, Italy, Serbia, Spain
COVID-19: IFRC warns Europe’s poorest countries are being left behind, as deaths hit grim milestone
As Europe reaches the grim milestone of 50 million infections and 1 million lives lost to COVID-19, IFRC calls for more equitable access to vaccination to counter disparities across countries and ensure no one is left behind.
21 April 2021


Institut Pasteur [to 24 Apr 2021]
Press release
SARS-CoV-2: infection induces antibodies capable of killing infected cells regardless of disease severity
Drawing on epidemiological field studies and the French COVID hospital cohort coordinated by Inserm, teams from the…


IRC International Rescue Committee [to 24 Apr 2021]
Media highlights [Selected]
No new digest content identified.


IVAC [to 24 Apr 2021]
Updates; Events
No new digest content identified.


IVI [to 24 Apr 2021]
Selected IVI News, Announcements, Events
Webinar | COVID-19 and Public Governance: Effective Global Vaccination Strategies for Vaccine Access
While vaccination campaigns are rolled out across the globe and access to safe and effective COVID-19 vaccines come into sight, more work, funding and collaboration are still needed to overcome the tremendous health and economic consequences of this pandemic. In this crisis, international cooperation needs to succeed—also to set itself up for further challenges to come. Register below!
April 29, 2021 | 9:30 Berlin | 16:30 Seoul


JEE Alliance [to 24 Apr 2021]
Selected News and Events
No new digest content identified.


Johns Hopkins Center for Health Security [to 24 Apr 2021]
Center News
No new digest content identified.


MSF/Médecins Sans Frontières [to 24 Apr 2021]
Latest [Selected Announcements
Pumps, bicycles and satellites: fighting malaria in Burundi
Project Update 22 Apr 2021

COVID-19 leaves high numbers of deaths and overwhelmed hospitals in Peru
Press Release 20 Apr 2021


National Academy of Medicine – USA [to 24 Apr 2021]
Selected News/Programs
Upcoming Events:
Researching Novel Therapeutics in a Pandemic: Lessons from COVID-19 (April 22)
Implementation Science and Non-Vaccine Public Health Measures during COVID-19 (April 23)
Exploring Influenza Vaccine Critical Inputs, Technologies, and Logistics Day 1 (April 23)
Exploring Influenza Vaccine Critical Inputs, Technologies, and Logistics Day 2 (April 27)


National Vaccine Program Office – U.S. HHS [to 24 Apr 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.


NIH [to 24 Apr 2021]
News Releases
COVID-19 vaccine responses to be studied in people with immune deficits
April 23, 2021 — Enrollment begins at NIH Clinical Center.

Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients begins
April 22, 2021 — Patients with acute respiratory failure may now enroll in NIH-sponsored trial.

Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19
April 21, 2021 — Study is part of an effort to speed development of the most promising treatments and vaccine candidates.

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
April 19, 2021 — Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.


UN OCHA Office for the Coordination of Humanitarian Affairs [to 24 Apr 2021]
Press Releases
20 April 2021
United Nations launches $29 million appeal for St. Vincent and the Grenadines and other affected countries as volcano eruption continues

18 April 2021
United Nations Resident Coordinator and Humanitarian Coordinator for Syria, Imran Riza, condemns killing of two aid workers in Deir-Ez-Zor, Syria [EN/AR]


PATH [to 24 Apr 2021]
Press Releases
No new digest content identified.


Sabin Vaccine Institute [to 24 Apr 2021]
Statements and Press Releases
No new digest content identified.


UNAIDS [to 24 Apr 2021]
Selected Press Releases/Reports/Statements
21 April 2021
Civil society from Asia and the Pacific join the first regional consultation on the High-Level Meeting on AIDS

19 April 2021
Regional network of people living with HIV launched in the Middle East and North Africa

19 April 2021
Less than 60% of pregnant women living with HIV in western and central Africa have access to services to stop vertical transmission of HIV


UNDP United Nations Development Programme [to 24 Apr 2021]
Latest from News Centre
No new digest content identified.


UNESCO [to 24 Apr 2021]
Selected Latest News
Making COVID-19 Vaccine a “global public good” for its timely allocation to Africa
…In this context, the Framework for Fair, Equitable and Timely Allocation of COVID-19 Vaccines in Africa, issued in January 2021 by Africa Centres for Disease Control and Prevention (Africa CDC) and the South African Medical Research Council (SAMRC), as well as the UNESCO Ethics Commissions’ Call for Global Vaccines Equity and Solidarity, issued in February 2021 as a joint statement by UNESCO International Bioethics Committee (IBC) and the World Commission on the Ethics of Scientific Knowledge and Technology (COMEST), needed to be reaffirmed for ensuring that a COVID-19 Vaccine is considered a “global public good” that is accessible to everyone, irrespective of ethnicity, nationality, gender, sexual orientation, race and religion. This is the rationale behind the Series of Community Engagement and Experience Sharing Virtual Workshops on Ethical Considerations in Covid-19 immunization campaigns for its fair, equitable and timely allocation in Africa, with the first of the series held on 14 April 2021.’’…


UNHCR Office of the United Nations High Commissioner for Refugees [to 24 Apr 2021]
Selected News Releases, Announcements
UNHCR’s Grandi calls on the international community to stand with DR Congo
23 Apr 2021



Mounting death toll in the Central Mediterranean calls for urgent action
23 Apr 2021



Data visualization reveals impacts of climate change on displacement
22 Apr 2021



UNHCR’s Protection Chief visits Cyprus, addresses challenges in access to asylum
22 Apr 2021



More refugees arrive in Chad following recent clashes in CAR
20 Apr 2021



Relocations in Brazil offer dignity and hope to thousands of Venezuelans
Joint UNHCR/IOM Press Release
20 Apr 2021


UNICEF [to 24 Apr 2021]
Selected Press Releases, Statements
Statement 04/23/2021
UNICEF Executive Director Henrietta Fore’s remarks at the one-year anniversary of the Access to COVID-19 Tools Accelerator
As prepared for delivery

Press release 04/23/2021
COVID-19 continues to disrupt essential health services in 90 per cent of countries
Some signs of recovery emerging but major efforts required to restore and strengthen health services

Press release 04/22/2021
UNICEF Goodwill Ambassador David Beckham leads global vaccination drive during World Immunization Week
Global partners pledge a $1 donation for every like, share or comment on social media posts mentioning ‘UNICEF’ using the hashtag #VaccinesWork until the end of April

Statement 04/22/2021
Syria receives its first delivery of COVID-19 vaccines through the COVAX Facility
Joint Statement by UNICEF Regional Director for the Middle East and North Africa, Ted Chaiban, WHO Regional Director for the Eastern Mediterranean, Dr. Ahmad Al-Mandhari, and Gavi, the Vaccine Alliance Director of Country Support, Pascal Bijleveld

Press release 04/19/2021
Nine times more migrant children in Mexico over the past three months – UNICEF


Unitaid [to 24 Apr 2021]
Featured News
23 April 2021
World Malaria Day : Unitaid commits to ensure increased and equitable access to life-saving tools against malaria
Geneva – Ahead of World Malaria Day, marked annually on April 25, Unitaid reaffirms its strong commitment to combat malaria by increasing its efforts to prevent, control, and ultimately eliminate the disease.
The emergence of COVID-19 more than one year ago has thrown health systems into disarray and forced many countries to shift their focus and resources away from malaria. This threatens to reverse hard-won gains, particularly in the highest malaria burden countries where the rate of progress has slowed in recent years.
The World Health Organization (WHO) warns countries that disruptions to programmes that prevent and treat malaria could lead to a potential doubling of malaria deaths in sub-Saharan Africa in 2020 compared to 2018.
A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria highlights the urgent need to scale-up the adaptative measures adopted to counter the impact of COVID-19 to ensure the continuing delivery of lifesaving health services for malaria…


Vaccination Acceptance Research Network (VARN) [to 24 Apr 2021]
No new digest content identified.


Vaccine Confidence Project [to 24 Apr 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).
[Data arrays do noy seem to loading]


Vaccine Education Center – Children’s Hospital of Philadelphia [to 24 Apr 2021]
No new digest content identified.


Wellcome Trust [to 24 Apr 2021]
News and reports
What are human infection studies and why do we need them?
19 April 2021


The Wistar Institute [to 24 Apr 2021]
Press Releases
Apr. 22, 2021
Low-dose Administration of MERS DNA Vaccine Candidate Induces Potent Immunity and Protects From Virus Challenge in Preclinical Models
Dose-sparing regimens and intradermal delivery have important implication for rapid clinical development of effective, well-tolerated and easy-to-distribute vaccines against MERS and other emerging coronaviruses.


WFPHA: World Federation of Public Health Associations [to 24 Apr 2021]
Latest News
Together We Can Overcome the COVID-19 Pandemic: Letters to G7 & G20
Apr 22, 2021
The COVID-19 pandemic is a global public health issue requiring a global solution with regional, national and local applicability. The extreme COVID-19 fatigue and uncertainty experienced by populations worldwide urgently requires both short-term and long-term practical solutions.
In countries that have been more successful in containing COVID-19, health and social professionals have been in leading roles formulating evidence-informed recommendations on the basis of best practice, and supporting societal engagement.
Therefore, the Coalition of Global Health, Primary Care and Social Work Professionals has sent an open letter to the Presidents of the 2021 G7 and G20 Summits to call on the G7 and G20 Summits to engage with the representatives of the Coalition to work directly on the co-design and co-production of local, national, regional and international strategies to effectively combat the COVID-19 global pandemic.
Together we can overcome the COVID-19 pandemic.
Letter to G7
Letter to G20

Advancing Essential Public Health Functions to Prevent the Next Pandemic
Apr 19, 2021
Advancing Essential Public Health Functions to Prevent the Next Pandemic
The Essential Public Health Functions (EPHFs) are a set of fundamental actions taken to achieve the public health goal of improving, promoting, protecting, and restoring the…


World Bank [to 24 Apr 2021]
Selected News, Announcements
COVID 19: Debt Service Suspension Initiative
In the interest of greater transparency, this webpage offers a country-by-country accounting of DSSI participants and the amounts they owe to creditors, based on information from the World Bank’s International…
Date: April 23, 2021 Type: Brief

World Bank Financing for COVID-19 Vaccine Rollout Reaches $2 Billion
Date: April 20, 2021 Type: Press Release
[See COVID – Access above for detail]

World Bank Approves $30 Million to Support COVID-19 Vaccination Rollout in Rwanda
WASHINGTON, April 16, 2021 — The World Bank’s Board of Executive Directors approved  $30 million in additional financing to the Republic of Rwanda for the acquisition and deployment of safe and…
Date: April 16, 2021 Type: Press Release


World Customs Organization – WCO [to 24 Apr 2021]
Latest News – Selected Items
20 April 2021
The SAFE Working Group endorses the SAFE 2021 Framework of Standards after a successful Review Cycle and paves the way to prioritize its activities in line with the WCO’s COVID-19 Action Plan


World Organisation for Animal Health (OIE) [to 24 Apr 2021]
Press Releases
No new digest content identified.


WTO – World Trade Organisation [to 24 Apr 2021]
WTO News and Events
Members note sharp downturn in LDCs’ trade, discuss role of trade in eradicating poverty
19 April 2021
An analysis of least-developed countries’ (LDCs) trade flows in 2020, presented to WTO members at a meeting of the Sub-Committee on LDCs on 19 April, revealed that the negative impact of the COVID-19 pandemic on trade was worse for LDCs than for the world as a whole. In addition, delegations discussed preparations for the Fifth United Nations Conference on LDCs as well as the latest research on LDCs carried out by the United Nations Conference on Trade and Development (UNCTAD)…
Introduced by UNCTAD, “The least-developed countries report 2020 — productive capacities for the new decade” notes that LDCs were innovative in setting up measures to combat the crisis, both productive and institutional. For example, Senegal came up with rapid COVID-19 testing facilities and Bangladesh revamped its manufacturing production capacity.
Yet, it is estimated that over 300 million people are still living in extreme poverty, according to UNCTAD. The organization’s new productive capacities index indicates that LDCs lag behind other developing countries in several productive capacity areas. The transition to a digital economy remains pending. This is due to costly adoption of new technological capabilities, to insufficient skills and inadequate infrastructure. Policies are needed to develop LDCs’ productive capacities through investment and industrial transition…





ARM [Alliance for Regenerative Medicine] [to 24 Apr 2021]
Press Releases – Alliance for Regenerative Medicine (
Press Releases
No new digest content identified.


BIO [to 24 Apr 2021]
Press Releases
Proposed “TRIPS” Waiver Is the WRONG Way To Attack Global Access for Vaccines to Developing Countries
April 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver”…


DCVMN – Developing Country Vaccine Manufacturers Network [to 24 Apr 2021]
News; Upcoming events
No new digest content identified.


ICBA – International Council of Biotechnology Associations [to 24 Apr 2021]
No new digest content identified.


IFPMA [to 24 Apr 2021]
Selected Press Releases, Statements, Publications
ACT-Accelerator 1-Year Anniversary: the biopharmaceutical industry is committed to continue to play a critical role
23 April 2021
[See COVAX above for detail]

COVID-19 vaccine industry cautions immediate action needed to remove manufacturing supply barriers to meet production
23 April 2021
[See COVAX above for detail]


PhRMA [to 24 Apr 2021]
Selected Press Releases, Statements
Data shows that Americans are relying on vaccines to get us through the pandemic
April 22, 2021
Data shows that Americans are relying on vaccines to get us through the pandemic.
Blog Post